Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 47   

Articles published

GSK 1,363.50 +18.00 (1.34%)
price chart
US top court rules for Glaxo on overtime pay
By a 5-4 vote, the high court handed a defeat to two former sales representatives for a unit of Britain's GlaxoSmithKline Plc. They had appealed a U.S. appeals court in California ruling that they were "outside sales" personnel exempt from federal ...
KineMed Announces Biomarker Discovery Collaboration with GSK
EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) that will apply KineMed's proprietary biomarker discovery platform in ...
Glaxo to Pay at Least $226 Million for Basilea's Toctino
GlaxoSmithKline Plc agreed to buy the marketing rights for Basilea Pharmaceutica AG's hand eczema drug Toctino for 146 million pounds ($226 million).
US approves Glaxo meningitis vaccine for children
The FDA had rejected MenHibrix twice before, in 2010 and 2011, but GlaxoSmithKline said it had resolved regulators' questions about the vaccine's potency and efficacy.
Glaxo CEO Says Europe Market 'Much' Worse Than Expected
GlaxoSmithKline Plc Chief Executive Officer Andrew Witty said, “What we've seen in the last three, four months is a much higher level of price pressure than we had anticipated, which is of course making short-term trading more challenging than expected.
Should investors embrace the profits of sin?
Investors are equally divided on another key component of the Saints: pharmaceuticals companies. GlaxoSmithKline (GSK) and AstraZeneca (AZN) are among the highest-yielding companies in the FTSE 100, yet the rising cost of drug discoveries coupled ...
Babcock steps up in FTSE reshuffle
Babcock International (BAB) will join the big boys of the FTSE 100 (UKX) as part of the quarterly reshuffle, while hedge fund manager Man Group (EMG) will fall back into the mid caps.
It's time to get over the gilt complex
The unending flight to quality in sovereign bonds has seen gilt prices soar and yields sink to levels that have rarely, if ever, been seen.
Makers' mark: why UK PLC is on the march
From world-leading companies such as GlaxoSmithKline in pharmaceuticals, BAE Systems in defence technology and Burberry in fashion, "Made in Britain" is still a label to be proud of, but there is less of it around than there used to be.
Boots Walgreens takeover: Buy-out could poison one of Britain's best-loved firms
This ought in theory be a good thing for consumers since the new Boots-Walgreen will have the distribution power to bargain hard with the big drugs firms like GlaxoSmithKline and the beauty-consumer products giants Proctor & Gamble and Unilever.